Clinical trial

Paliperidone Extended-Release (ER) Versus Risperidone for Neurocognitive Function in Patients With Schizophrenia

NCT00827840

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-11-01

PhasePHASE4

Study timeline

Study start (unknown)2008-11-01Date precision: month

Registry last updated2011-12-23

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Schizophreniaunresolved

Interventions

Paliperidone ERDRUG

RisperidoneDRUG · verified · RxNorm: risperidone

Sponsors & collaborators

Chonnam National University Hospitallead sponsor

Janssen Korea, Ltd., Koreacollaborator

Ministry of Health, Republic of Koreacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00827840 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.